NV556



NAME OF DRUG : NV556

ALSO KNOWN AS : NV556

LABORATORY : NeuroVivePharmaceuticalAB

STATUS AND ADVANCEMENT

Type of drug : mild mitochondrial protonophores

Clinical trials advancement : Preclinic

Estimated time to market : 134 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON NV556

SOME PUBLICATIONS RELATED WITH NV556

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH NV556


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE